Biotech Target N V - 09 Jun 2021 Form 3 Insider Report for MACROGENICS INC (MGNX)

Role: 10%+ Owner
Signature: /s/ Daniel Koller
Issuer symbol: MGNX
Transactions as of: 09 Jun 2021
Transactions value $: $0
Form type: 3
Filing time: 11 Jun 2021, 17:21:42 UTC
Previous filing: 26 May 2021
Next filing: 17 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MGNX	Common Stock						6.03M	09 Jun 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Macrogenics, Inc. held directly or indirectly by Biotech Target N.V. The Form 3 is jointly filed by BB Biotech AG and Biotech Target N.V.